22 U.S.C. § 7635: Report on treatment…

Summary

The President must send a report to the proper congressional committees no later than 15 months after May 27, 2003. The report is about what U.S. agencies are doing to treat people with HIV or AIDS in other countries. The report must cover six main topics: treating infections that come with HIV, use of antiretroviral drugs, the status of research on treatment plans for developing countries, training and technical help for local health workers to give drugs and monitor patients, plans to keep HIV medicines available and how drug resistance affects patients, and what law enforcement is doing to stop counterfeit or black‑market drugs. It must also describe any pilot projects (why they were chosen, how many treated, costs, safety checks, and plans and timelines to expand them) and say how these treatment activities relate to preventing HIV transmission.

Title 22, §7635

Foreign Relations and Intercourse, Source: USLM XML via OLRC

(a)In general

Not later than 15 months after May 27, 2003, the President shall submit to appropriate congressional committees a report on the programs and activities of the relevant executive branch agencies that are directed to the treatment of individuals in foreign countries infected with HIV or living with AIDS.

(b)Report elements

The report shall include—

(1)a description of the activities of relevant executive branch agencies with respect to—

(A)the treatment of opportunistic infections;

(B)the use of antiretrovirals;

(C)the status of research into successful treatment protocols for individuals in the developing world;

(D)technical assistance and training of local health care workers (in countries affected by the pandemic) to administer antiretrovirals, manage side effects, and monitor patients’ viral loads and immune status;

(E)the status of strategies to promote sustainability of HIV/AIDS pharmaceuticals (including antiretrovirals) and the effects of drug resistance on HIV/AIDS patients; and

(F)the status of appropriate law enforcement officials working to ensure that HIV/AIDS pharmaceutical treatment is not diminished through illegal counterfeiting and black market sales of such pharmaceuticals;

(2)information on existing pilot projects, including a discussion of why a given population was selected, the number of people treated, the cost of treatment, the mechanisms established to ensure that treatment is being administered effectively and safely, and plans for scaling up pilot projects (including projected timelines and required resources); and

(3)an explanation of how those activities relate to efforts to prevent the transmission of the HIV infection.

Notes & Related Subsidiaries

Executive Documents

Delegation of Functions For delegation of functions of President under this section, see Ex. Ord. No. 12163, Sept. 29, 1979, 44 F.R. 56673, as amended, set out as a note under section 2381 of this title, and Memorandum of President of Feb. 23, 2004, 69 F.R. 9509, set out as a note under section 7611 of this title.

§7635 Report on Treatment Activities by Relevant Executive Branch Agencies

Summary

Title 22, §7635

Notes & Related Subsidiaries

Executive Documents

Citations & Metadata